About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Pfizer Demands DNA of Trovan Victims Who Are Owed Compensation

By Jim Edwards | Nov 2, 2009

Victims covered by Pfizer’s $75 million settlement of the Trovan meningitis case in Nigeria must produce DNA tests before they will receive their part of the payout, according to This Day, an African news web site.

The news comes after it emerged that Nigerian officials had lost the list of those affected by the disasterous drug trial. Pfizer has its own list of the victims, but Nigerian officials don’t want to rely on it.

An official involved in administering the money, retired Supreme Court justice Abubakar Wali, said:

“…all the victims must undergo DNA test to ensure that the genuine victims benefit from the settlement.”

Back story: The case stems from tests Pfizer did in 1996 during a meningitis outbreak in the African nation. Eleven children died. Trovan’s use was restricted in the U.S. and banned in Europe. The events may have inspired the book and movie, The Constant Gardener.

Admin costs for distributing the compensation have already been estimated at $4.5 million to $5 million. About $30 million will go to the children affected by the trial. Now, according to This Day, even victims who present DNA tests indicating they are on the list of victims may have to wait until 2011 for their money.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Pfizer Close to Settling Trovan Case in Nigeria

    BNET Pharma - 260 days 15 hours 54 minutes ago

    Pfizer is close to settling the Trovan litigation in Nigeria, and may have whittled the plaintiffs down to as little as $75 million. The case stems from tests Pfizer did in 1996 during a meningitis outbreak in the African nation. Eleven children died. Trovan's use was restricted in the U.S. and banned in Europe. The events may have inspired the...

  • Pfizer - Trovan: $75 million settlement$

    PharmaGossip - 117 days 3 hours 15 minutes ago

    NIGERIA - Kano State government will on Thursday formally sign a historic agreement with Pfizer, the multi-national drug producers, over the contentious drug trial associated with a cerebro-spinal meningitis outbreak in the state in 1996. The final out-of-court settlement in a multi-billion-dollar lawsuit over the trial of meningitis drug,...

  • Pfizer - Trovan: nearly out of Africa?

    PharmaGossip - 234 days 23 minutes ago

    Back stories here Nigeria is close to reaching a $75 million out-of-court settlement with Pfizer Inc over a 1996 drug trial it says killed 11 children and left dozens disabled, sources close to the negotiations said on Wednesday. Nigeria's federal government and its northern state of Kano sued the world's largest drugmaker in May 2007 for...

  • Pfizer settles Nigerian Trovan trial case out of court

    In-Pharma Technologist - 229 days 23 hours 14 minutes ago

    Prosecutors in the northern Nigerian state of Kano had been seeking $2.75bn (€2bn) in compensation from the US drug giant, accusing it of conducting an unlicensed trial of the drug in 200 children during a meningitis epidemic in 1996. While details of the settlement are not due to be released until May 25, various media reports suggest Pfizer...

  • Pfizer - Trovan: this sad case continues

    PharmaGossip - 20 days 12 hours 5 minutes ago

    $75m: Pfizer Demands DNA Report from Beneficiaries From Ibrahim Shuaibu in Kano, 11.01.2009 Add To Favorites Print This Article Post Comment Pfizer International, the US pharmaceutical company that carried out a meningitis trovan test in 1996 on a number of children in Kano State, has demanded a Deoxyribonucleic Acid (DNA)...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here